Ectopically Expressed CAG Repeats Cause Intranuclear Inclusions and a Progressive Late Onset Neurological Phenotype in the Mouse

Cha, 1994, Trinucleotide repeats in neurologic diseases, Life Sci., 54, 1459, 10.1016/0024-3205(94)90012-4 David, 1997, Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion, Nat. Genet., 17, 65, 10.1038/ng0997-65 Davies, 1997, Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation, Cell, 90, 537, 10.1016/S0092-8674(00)80513-9 DiFiglia, 1997, Aggregation of Huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain, Science, 277, 1990, 10.1126/science.277.5334.1990 Dunnett, 1989, Monoamine deficiency in a transgenic (Hprt-) mouse model of Lesch-Nyhan syndrome, Brain Res., 501, 401, 10.1016/0006-8993(89)90659-8 Finger, 1988, Behavioral and neurochemical evaluation of a transgenic mouse model of Lesch-Nyhan syndrome, J. Neurol. Sci., 86, 203, 10.1016/0022-510X(88)90099-8 Gusella, 1996, Huntington's disease, Cold Spring Harb. Symp. Quant. Biol., 61, 615, 10.1101/SQB.1996.061.01.062 Hooper, 1987, HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells, Nature, 326, 292, 10.1038/326292a0 Ikeda, 1996, Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo, Nat. Genet., 13, 196, 10.1038/ng0696-196 Jinnah, 1991, Amphetamine-induced behavioral phenotype in a hypoxanthine-guanine phosphoribosyltransferase-deficient mouse model of Lesch-Nyhan syndrome, Behav. Neurosci., 105, 1004, 10.1037/0735-7044.105.6.1004 Jinnah, 1993, Brain purines in a genetic mouse model of Lesch-Nyhan disease, J. Neurochem., 60, 2036, 10.1111/j.1471-4159.1993.tb03488.x Jinnah, 1994, Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease, J. Neurosci., 14, 1164, 10.1523/JNEUROSCI.14-03-01164.1994 Kazemi-Esfarjani, 1995, Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor, Hum. Mol. Genet., 4, 523, 10.1093/hmg/4.4.523 Lobo Ruppert, 1996, Monoclonal antibodies directed against the amino-terminal domain of human TBP cross-react with TBP from other species, Hybridoma, 15, 55, 10.1089/hyb.1996.15.55 Mangiarini, 1996, Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice, Cell, 87, 493, 10.1016/S0092-8674(00)81369-0 Matilla, 1997, The cerebellar leucine rich acidic nuclear protein (LANP) interacts with ataxin-1, Nature, 389, 974, 10.1038/40159 Nagy, 1993, Derivation of completely cell culture-derived mice from early-passage embryonic stem cells, Proc. Natl. Acad. Sci. USA, 90, 8424, 10.1073/pnas.90.18.8424 Nasir, 1996, Huntington disease, Hum. Mol. Genet., 5, 1431, 10.1093/hmg/5.Supplement_1.1431 Ordway, 1996, In vitro synthesis and cloning of long CAG repeats, Biotechniques, 21, 609, 10.2144/96214bm08 Orr, 1996, Toward understanding polyglutamine-induced neurological disease in spinocerebellar ataxia type 1, Cold Spring Harb. Symp. Quant. Biol., 61, 649, 10.1101/SQB.1996.061.01.065 Paulson, 1997, Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3, Neuron, 19, 333, 10.1016/S0896-6273(00)80943-5 Quarrell, O., and Harper, P. (1991). The clinical neurology of Huntington's disease. In Huntington's Disease, P.S. Harper, ed. (London: W.B. Saunders Company Ltd.), pp. 37–80. Reddy, 1997, The complex pathology of trinucleotide repeats, Curr. Opin. Cell Biol., 9, 364, 10.1016/S0955-0674(97)80009-9 Ross, 1995, When more is less, Neuron, 15, 493, 10.1016/0896-6273(95)90138-8 Saudou, 1996, Polyglutamine expansions and neurodegenerative diseases, Cold Spring Harb. Symp. Quant. Biol., 61, 639, 10.1101/SQB.1996.061.01.064 Scherzinger, 1997, Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo, Cell, 90, 549, 10.1016/S0092-8674(00)80514-0 Skinner, 1997 Strittmatter, 1997, Protein:protein interactions in Alzheimer's disease and the CAG triplet repeat diseases, Cold Spring Harb. Symp. Quant. Biol., 61, 597 Trottier, 1995, Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias, Nature, 378, 403, 10.1038/378403a0 Vonsattel, 1985, Neuropathological classification of Huntington's disease, J. Neuopathol. Exp. Neurol., 44, 559, 10.1097/00005072-198511000-00003 Williamson, 1992, Mouse models of hypoxanthine phosphoribosyltransferase deficiency, J. Inherit. Metab. Dis., 15, 665, 10.1007/BF01799622 Zhuchenko, 1997, Autosomal dominant cerebellar ataxia (sca6) associated with small polyglutamine expansions in the alpha(1a)-voltage-dependent calcium channel, Nat. Genet., 15, 62, 10.1038/ng0197-62 Zoghbi, 1996, The expanding world of ataxins, Nat. Genet., 14, 237, 10.1038/ng1196-237